DSpace Repository

Working Capital Management: an Empirical Study of Beximco Pharma in Bangladesh

Show simple item record

dc.contributor.author Neloy, Arafat Hosain
dc.date.accessioned 2020-11-04T05:41:51Z
dc.date.available 2020-11-04T05:41:51Z
dc.date.issued 2020-08-12
dc.identifier.uri http://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/4941
dc.description To determine the working capital position and need for working capital at first we have to know about the company because working capital is required on the basis of the company’s goal, objective, and policy. Beximco Pharmaceuticals Ltd (Beximco Pharma) is a driving producer and exporter of prescription in Bangladesh. Integrated in the late 70s, Beximco Pharma leads off as a reseller, importing Goods from worldwide MNCs like Bayer, Germany, and Upjohn, USA, and marketing them in the local market, which was later constructed and scattered under the approval system. Since then, the journey ongoing, and today, Beximco Pharma is one of the broader exporters of medicines in Bangladesh, victorious National Export Trophy (Gold) a record five times. The company continues to stick to the universal standards and its production accommodations have been beforehand qualified by the statutory administration of the USA, Europe, Australia, Canada, Latin America, and South Africa. Over the last three decades Beximco Pharma evolved from strength to strength, but the pure notion on which it was established residue the same: manufacturing high-quality generics and making them cost-effective. Ensuring entrance to standard medicines is the impressive l ambition that drives greater than 3,800 employees of the company, and everyone is directed by the same ethical and social responsibilities the company values most. They always seek to give our best access to standard quality and low cost so that affordable for everyone's medicines main reason they know good health cannot be bought it is priceless. Beximco Pharmaceuticals Ltd (Beximco Pharma) is a novel generic medicine player promised to give easy access to affordable medicines for all class people. The company’s state-of-the-art producing facilities have been certified by the standard regulatory authorities of the USA, Australia, the European Union, Canada, and Brazil, among others, and it has recently focused on providing a presence in many nascent and devised markets around the world. Beximco Pharma is systematically constructed upon its portfolio and recently manufacturing more than 500 goods, encompassing broad curative categories and the Company has established strong and powerful differentiation by offering a selection of high-tech, specialized products that are challenging to emulate. en_US
dc.description.abstract Working capital is a financial measure which stands for functioning liquidity accessible to a business, organization, or other institution, for example, governmental institution. Along with permanent assets, for example, building and equipment, working capital have deemed a component of operating capital. There are four basic parts of the working capital. To meet the daily obligation and to run an organization smoothly organization keep working capital. And to maintain working capital managers should think two different sides 1) if they hold more working capital, then they keep the more liquid money on hand for this they could invest less. 2) If they hold less liquid money on hand than they face problems to meet their daily obligation. So working capital or liquid money should behold at a rate where they easily meet their daily obligation and also consider investing. Investment is the main motive of an organization, working capital is also an investment to run the organization smoothly. This paper determines at which rate the organization should take working capital or effectively use working capital. The necessity for working capital fluctuates from industry to industry, and they can even differ among comparable companies. This is because of various ingredients, for example, the divergence in the compilation and settlement policies, Time of asset purchases, the possibility of a company script off a few its past accounts receivable due, and on any occasion, capital-breeding attempt a company is an endeavor. Working capital is the part and parcel of an organization to manage it’s a daily obligation. Beximco Pharma was established in 1976 and launched activities in 1980, it’s the leading manufacturing company in Bangladesh. It produces goods under the licenses of Bayer AG of Germany and Upjohn Inc. of the United States. Nowadays Beximco Pharma produces and markets its qualified generics for various diseases in particular AIDS, cancer, asthma, hypertension for both domestic and global markets. This study is based on working capital management. To manage such a massive organization working capital is very essential. Excessive and deficit working capital, both harmful to an organization. The need for working capital is based on the nature of business. Bangladesh is a developing country and its GDP is increasing day by day. Overpopulation is not the only curse but also a blessing because of cheap human resources. It follows a mixed economy (capitalism and socialism) for this business organization to find a suitable environment. In the medicine industry, Bangladesh has a good fame in the international market. Working capital and economic situation have a positive relation. Economic situation impact on organization function. en_US
dc.language.iso en en_US
dc.publisher Daffodil International University en_US
dc.subject Human Capital--Management en_US
dc.subject Pharmaceutical Industry en_US
dc.title Working Capital Management: an Empirical Study of Beximco Pharma in Bangladesh en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account